Document is current
Any future updates will be listed below
-
Authors
Hallaert, Patrick
Roman, John W.
Baker, Mairead
Hill, Natasha T.
Marte, Jennifer L.
Gulley, James L.
Logemann, Nicholas
Hudgens, Courtney W.
Reuben, Alexandre
Brownell, Isaac
-
Funding
Funding for this research was provided by:
NIAMS Intramural Research Program (ZIA AR041222)
- License Information
-
More Information
Article History
Received: 19 February 2025
Accepted: 2 June 2025
First Online: 1 July 2025
Competing interests
: P.H., J.W.R., M.B., N.T.H., J.L.M., N.L., C.W.H., A.R., and I.B. declare no conflicts of interest. J.L.G. works for the National Cancer Institute which has a Cooperative Research and Development Agreements (CRADA) with EMD Serono. This CRADA provided resources for the co-development of avelumab in MCC. The views expressed in this article are those of the authors and do not reflect the official policy of the Department of Defense or U.S. Government.
: The authors obtained written consent from patients for their photographs and medical information to be published in print and online and with the understanding that this information may be publicly available.
